Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
68
PROK Quote, Financials, Valuation and Earnings
Last price:
$2.54
Seasonality move
:
5.06%
Day range:
$2.47 - $2.56
52-week range:
$0.46 - $7.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
444.41x
P/B ratio:
--
Volume:
693.1K
Avg. volume:
1.3M
1-year change:
40.56%
Market cap:
$358.1M
Revenue:
$76K
EPS (TTM):
-$0.54
Earnings Data
Next earnings date for PROK
Mar 24
2026
Most recent earnings per share
-$0.12
Beat by $0.01
(Nov 10/2025)
Consensus Estimate
-$0.14
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PROK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q4 | -$39.4K | -- | -- | -$0.15 | -- |
| 11/10/2025 | Q3 | $44.3K | $217K | -$0.12 | -$0.14 | $0.01 |
| 08/12/2025 | Q2 | -- | $221K | -$0.13 | -$0.14 | $0.02 |
| 05/12/2025 | Q1 | -- | $230K | -$0.13 | -$0.15 | $0.02 |
| 03/17/2025 | Q4 | -- | $76K | -$0.17 | -$0.15 | -$0.02 |
| 11/12/2024 | Q3 | -- | -- | -$0.14 | -$0.22 | $0.07 |
| 08/09/2024 | Q2 | -- | -- | -$0.16 | -$0.18 | $0.01 |
| 05/10/2024 | Q1 | -- | -- | -$0.16 | -$0.18 | $0.02 |
| 03/21/2024 | Q4 | -- | -- | -$0.10 | -$0.18 | $0.09 |
| 11/14/2023 | Q3 | -- | -- | -$0.18 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.14 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.16 | -- | -- |
| 03/28/2023 | Q4 | -- | -- | -$0.11 | -- | -- |
| 11/14/2022 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.36 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.10 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.22 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.54 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.00 | -- | -- |
ProKidney Corp. Earnings Questions
-
How Much did ProKidney Corp. Generate in Revenue Last Quarter?
ProKidney Corp. reported $217K worth of top line sales in its most recent quarter.
-
Did ProKidney Corp. Beat Earnings Last Quarter?
ProKidney Corp. announced earnings per share of -$0.12 which represents a beat of analyst forecast a -$0.14 per share.
-
Is ProKidney Corp. Profitable?
ProKidney Corp. reported -$1.2M that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for ProKidney Corp. EPS Next Year?
ProKidney Corp.'s earnings are forecast to decrease from -$0.62 per share to -$0.59 per share next year representing a decrease of -5.93%.
-
When is ProKidney Corp.'s Earnings Date?
ProKidney Corp.'s next earnings date is March 24, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
